Digital Interventions to Increase HPV Vaccination Intentions Among Nigerian Caregivers
Recruiting
N/A
Interventional Study
HPV
HPV Vaccine
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
At a Glance
- Age
- 27 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Prevention
- Participants needed
- 3,340 (estimated)
- Sponsor
- University of Pennsylvania · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This study evaluates whether different types of digital health communication can increase parents' intention to vaccinate their daughters against human papillomavirus (HPV) in Nigeria. HPV vaccination is recommended for girls aged 9-14 years and helps prevent cervical cancer, yet vaccination rates remain low.
Parents of eligible, unvaccinated girls will be randomly assigned to receive one of seve…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Parent or primary caregiver of at least one girl aged 9-14 years
* Parent states "no" or "unsure" to question asking if eligible daughter has received any doses of the HPV vaccine
* Provides informed consent to participate
Exclusion Criteria:
* Parent or caregiver of a girl …
Contacts
No contact information available.